JasmohanSBajajMD

Hepatology & Liver Transplantation

Associate Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine

Join to view full profile

Dr. Bajaj is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bajaj's full profile

Already have an account?

Office
1250 E Marshall St
Internal Medicine
Richmond, VA 23298
Phone+1 804-828-8508

Fax+1 804-828-5348

Education & Training

Medical College of Wisconsin Affiliated HospitalsFellowship, Gastroenterology, 2002 - 2005
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1999 - 2002
Maulana Azad Medical CollegeClass of 1998

Certifications & Licensure

VA State Medical License 2008 - 2026
WI State Medical License 2003 - 2025
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology

Clinical Trials

Effect of Yogurt on Minimal Hepatic Encephalopathy Start of enrollment: 2005 Nov 01
Completed
Not Applicable
Rifaximin in Minimal Hepatic Encephalopathy Start of enrollment: 2007 Oct 01
Completed
Not Applicable
Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy Start of enrollment: 2009 Oct 01
Completed
Phase 1
Study of Rifaximin in Minimal Hepatic Encephalopathy Start of enrollment: 2010 Feb 01
Completed
Phase 1, Phase 2
Proton Pump Inhibitors and Dysbiosis in Cirrhosis Start of enrollment: 2011 Oct 01
Completed
Not Applicable
Effect of Tolvaptan on Cognitive Function in Cirrhosis Start of enrollment: 2011 Apr 01
Completed
Phase 3
Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03
Terminated
Phase 4
iPod Games in Hepatic Encephalopathy Start of enrollment: 2013 Jan 01
Completed
Not Applicable
Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis Start of enrollment: 2015 Aug 01
Completed
Fecal Transplant in Recurrent Hepatic Encephalopathy Start of enrollment: 2015 Oct 01
Completed
Phase 1
Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis Start of enrollment: 2016 Jun 01
Completed
Not Applicable
Oral Gut Liver Axis in Cirrhosis Start of enrollment: 2016 Oct 01
Completed
Not Applicable
Ramelteon for Treatment of Insomnia in Cirrhosis Start of enrollment: 2017 Feb 01
Completed
Phase 4
Oral Fecal Transplant in Cirrhosis Start of enrollment: 2017 Jun 12
Completed
Phase 1
Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis Start of enrollment: 2018 Feb 01
Completed
Phase 1
Health IT Generated PROs to Improve Outcomes in Cirrhosis Start of enrollment: 2018 Jun 22
COMPLETED
NA
FMT in Cirrhosis and Hepatic Encephalopathy Start of enrollment: 2019 Jul 29
Completed
Phase 1, Phase 2
Rifamycin in Minimal Hepatic Encephalopathy Start of enrollment: 2019 Sep 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Interaction of the Gut-Liver-Brain Axis and the sterolbiome with sexual dysfunction in patients with cirrhosis.
Spencer C Harris, Jasmohan S Bajaj
Gut Microbes. 2025-12-01
Corrigendum to 'A Possible Reversible Cause of Cognitive Impairment: Undiagnosed Cirrhosis and Potential Hepatic Encephalopathy in Patients with Dementia' [The America...
Scott Silvey, Richard K Sterling, Evan French, Michael Godschalk, Angela Gentili
The American Journal of Medicine. 2025-03-26
Rifaximin does not increase the rate of 30-day mortality in patients with cirrhosis and daptomycin in two National US-based cohorts.
Scott Silvey, Nilang Patel, Alexander Khoruts, Jasmohan S Bajaj
Gastroenterology. 2025-03-21

Journal Articles

Reply (To LTE HEP‐18‐1401)
Patrick S Kamath, Jasmohan S Bajaj, Hepatology
The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients with Cirrhosis
Jasmohan S Bajaj, Jennifer C Lai, Scott W Biggins, Patrick S Kamath, Paul Thuluvath, Ram M Subramanian, Nature
Proton Pump Inhibitor Initiation and Withdrawal Affects Gut Microbiota and Readmission Risk in Cirrhosis
Michael Fuchs, Puneet Puri, Mohammad S Siddiqui, Douglas M Heuman, Jasmohan S Bajaj, Arun J Sanyal, Velimir Luketic, Richard K Sterling, Nature

Other

Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients with Cirrhosis
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/a2c73277-6791-46c4-90de-cff1de1d0b85
UpToDate, Wolters Kluwer Health - 2012-11-20
Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients with Cirrhosis
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/a2c73277-6791-46c4-90de-cff1de1d0b85
UpToDate, Wolters Kluwer Health - 2012-06-27
Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients with Cirrhosis
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/a2c73277-6791-46c4-90de-cff1de1d0b85
UpToDate, Wolters Kluwer Health - 2012-12-17
Current Management of Hepatic Encephalopathy
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/e9f24f02-2d3c-4402-9aef-fc842953291b
UpToDate, Wolters Kluwer Health - 2012-10-18
Current Management of Hepatic Encephalopathy
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/e9f24f02-2d3c-4402-9aef-fc842953291b
UpToDate, Wolters Kluwer Health - 2013-04-05
Current Management of Hepatic Encephalopathy
Jasmohan Bajaj, MD, Nature
https://www.doximity.com/articles/e9f24f02-2d3c-4402-9aef-fc842953291b
UpToDate, Wolters Kluwer Health - 2013-04-05
Join now to see all

Press Mentions

FMT Safe, Linked to Reduced Hepatic Encephalopathy Recurrence in Patients with CirrhosisFebruary 24th, 2025
Sweat Sensors Could Help Monitor Patients with Liver Disease, New Study FindsJanuary 23rd, 2025
AJG Special Issue on Inflammation Includes Updates ACG Guideline on Eosinophilic EsophagitisJanuary 17th, 2025
Join now to see all

Grant Support

Fecal microbiota transplant for Alcohol-Associated CirrhosisVIRGINIA COMMONWEALTH UNIVERSITY2022–2027
Evaluation of individual FMT as a potential therapeutic to reduce ethanol drinking in miceVIRGINIA COMMONWEALTH UNIVERSITY2024–2026
BCCMA: Targeting Gut Microbiome in Gastrointestinal and Liver Diseases in US Veterans; CMA4: At the Crossroads of the Gut Microbiome, Cirrhosis, and PTSDVA VETERANS ADMINISTRATION HOSPITAL2022–2026
BCCMA: Targeting Gut Microbiome in Gastrointestinal and Liver Diseases in US Veterans; CMA4: At the Crossroads of the Gut Microbiome, Cirrhosis, and PTSDVA VETERANS ADMINISTRATION HOSPITAL2022–2026
BCCMA: Targeting Gut Microbiome in Gastrointestinal and Liver Diseases in US Veterans; CMA4: At the Crossroads of the Gut Microbiome, Cirrhosis, and PTSDVA VETERANS ADMINISTRATION HOSPITAL2022–2026
BCCMA: Targeting Gut Microbiome in Gastrointestinal and Liver Diseases in US Veterans; CMA4: At the Crossroads of the Gut Microbiome, Cirrhosis, and PTSDVA VETERANS ADMINISTRATION HOSPITAL2022–2026
BCCMA: Targeting Gut Microbiome in Gastrointestinal and Liver Diseases in US Veterans; CMA4: At the Crossroads of the Gut Microbiome, Cirrhosis, and PTSDVA VETERANS ADMINISTRATION HOSPITAL2022–2026
Liver Cirrhosis Network: Clinical Research CentersVIRGINIA COMMONWEALTH UNIVERSITY2021–2026
Fecal Microbiota Transplant in Veterans with CirrhosisVA VETERANS ADMINISTRATION HOSPITAL2015–2025
Fecal Microbiota Transplant in Veterans with CirrhosisVA VETERANS ADMINISTRATION HOSPITAL2015–2025
Fecal Microbiota Transplant in Veterans with CirrhosisVA VETERANS ADMINISTRATION HOSPITAL2015–2025
Fecal Microbiota Transplant in Veterans with CirrhosisVA VETERANS ADMINISTRATION HOSPITAL2015–2025
Fecal Microbiota Transplant in Veterans with CirrhosisVA VETERANS ADMINISTRATION HOSPITAL2015–2025
Spectrum Of Neuro-Cognitive Impairment In CirrhosisNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
Hepatic Encephalopathy In Alcoholic Cirrhosis: A Systems Biology ApproachNational Institute On Alcohol Abuse And Alcoholism2010–2011
Probiotic Yogurt For The Treatment Of Minimal Hepatic EncephalopathyNational Center For Complementary &Alternative Medicine2009–2011
The Natural History Of Minimal Hepatic Encephalopathy And Its Effect On PsycNational Center For Research Resources2009–2010
Yogurt StudyNational Center For Research Resources2006